Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 5, May, p. 667–671

doi: 10.17219/acem/68718

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Management of gastrointestinal stromal tumors: A 10-year experience of a single surgical department

Dariusz Janczak1,2,A,F, Jacek Rać1,B,D, Wiktor Pawłowski1,2,A,D, Tadeusz Dorobisz1,3,C,E, Agnieszka Ziomek1,2,B, Dawid Janczak3,C,D, Michał Leśniak1,2,C,E, Mariusz Chabowski1,2,D,F

1 Department of Surgery, 4th Military Teaching Hospital, Wrocław, Poland

2 Division of Surgical Procedures, Department of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, Poland

3 Division of Oncology and Palliative Care, Faculty of Health Sciences, Wroclaw Medical University, Poland


Background. Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive system. The primary location of GISTs is mainly the gastrointestinal system. Clinical symptoms are nonspecific and mainly depend on the location and size of the tumor.
Objectives. The aim of this study was to conduct a clinical and pathological analysis of 18 cases of GISTs from the medical records of the Department of Surgery at the 4th Military Teaching Hospital in Wrocław, Poland.
Material and Methods. The medical records were of women and men at the age of 36–84 years who were treated in the Surgical Clinic. The medical data that was gathered included clinical records, histopathological results and the type of surgical treatment. The study also encompassed the anatomical location and size of the tumor as well as microscopic examination of the tumor.
Results. In most cases, GISTs were located in the stomach. The most common symptoms were stomachaches and signs of bleeding into the digestive system. Usually, the tumor presented a diameter of <5 cm and a low grade of malignancy. Out of 18 patients, 16 were treated with laparoscopic resection, whereas in the remaining 2 cases, multiorgan resections were carried out, because the tumor was locally advanced.
Conclusion. It is essential to distinguish stromal tumors from other mesenchymal tumors, since GISTs are among the cancers that have a high risk of malignant progression. The conditions for successful treatment are a properly established histopathological diagnosis, accompanied by immunohistochemical tests for CD117, and a combination of antibodies for a differential diagnosis of other mesenchymal tumors.

Key words

gastrointestinal stromal tumor, CD117, tumorectomy, jejunal gastrointestinal stromal tumor, stomach gastrointestinal stromal tumor

References (16)

  1. Głuszek S, Rylski R, Kot M, et al. GIST: Risk of recurrence and dissemination. Gastroenterol Rev. 2008;3(4):176–184.
  2. Prywinski S, Szopiński J, Wierzchowski P, Dąbrowiecki S. Gastrointestinal stromal tumor of small intestine as the cause of massive gastrointestinal hemorrhage: Case report. Pol Surg. 2008;10(2):107–112.
  3. Wang YP, Li Y, Song C. Clinicopathological features and prognosis of small gastrointestinal stromal tumors outside the stomach. Oncol Lett. 2015;10(5):2723–2730.
  4. Yacob M, Inian S, Sudhaker CB. Gastrointestinal stromal tumors: Review of 150 cases from a single centre. Indian J Surg. 2015;77(2):505–510.
  5. Ruka W, Debiec-Rychter M, Rutkowski P, et al. Current diagnostic and therapeutic management of patients with gastrointestinal stromal tumor (GIST). J Oncol. 2007;57(2):181–189.
  6. Akahoshi K, Sumida Y, Matsui N, et al. Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine-needle aspiration. World J Gastroenterol. 2007;13(14):2077–2082.
  7. Guzińska-Ustymowicz K, Nasierowska-Guttmejer A. Nowotwory podścieliskowe przewodu pokarmowego. Pol J Pathol. 2013;64(4) (Suppl 2):47–54.
  8. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29(1):52–68.
  9. Kim IH, Kim IH, Kwak SG, Kim SW, Chae HD. Gastrointestinal stromal tumors (GISTs) of the stomach: A multicenter, retrospective study of curatively resected gastric GISTs. Ann Surg Treat Res. 2014;87(6):298–303.
  10. Feng F, Liu Z, Zhang X, et al. Comparison of endoscopic and open resection for small gastric gastrointenstinal stromal tumor. Transl Oncol. 2015;8(6):504–508.
  11. Honda M, Hiki N, Nunobe S, et al. Long-term and surgical outcomes of laparoscopic surgery for gastric gastrointestinal stromal tumors. Surg Endosc. 2014;28(8):2317–2322.
  12. Morrison JE, Hodgdon IA. Laparoscopic management of obstructing small bowel GIST tumor. JSLS. 2013;17(4):645–650.
  13. Din OS, Woll PJ. Treatment of gastrointestinal stromal tumor: Focus on imatinib mesylate. Ther Clin Risk Manag. 2008;4(1):149–162.
  14. Matthews BD, Walsh RM, Kercher KW, et al. Laparoscopic vs open resection of gastric stromal tumors. Surg Endosc. 2002;16(5):803–807.
  15. Fu C, Liu N, Deng Q, Tan Y, Ma K, Bie P. Successful treatment of gastrointestinal stromal tumor with multiple liver metastases with radiofrequency ablation and imatinib: A case report. Oncol Lett. 2015;10(2):875–878.
  16. Hakime A, Le Cesne A, Deschamps F, et al. A role for adjuvant RFA in managing hepatic metastases from gastrointestinal stromal tumors (GIST) after treatment with targeted systemic therapy using kinase inhibitors. Cardiovasc Intervent Radiol. 2014;37(1):132–139.